Kyropan-D
Dual Release Protection Against Acid Reflux & Dyspepsia
Pantoprazole 40 mg & Domperidone SR 30 mg capsules
Detailed Formulation & Active Ingredients
Each hard gelatin capsule contains:
Pantoprazole Sodium (as enteric coated pellets) equivalent to Pantoprazole 40 mg
Domperidone (as sustained release pellets) 30 mg.
Therapeutic Indications & Clinical Scope
Gastroesophageal Reflux Disease (GERD), non-ulcer dyspepsia, diabetic gastroparesis, hyperacidity associated with nausea, and peptic ulcer disease.
Dosage & Administration
One capsule daily in the morning before food or as directed by the physician.
Notice: Dosage schedules should be tailored according to clinical assessment and physician direction.
Storage & Handling Guidelines
Store below 25°C in a dry place. Protect from light.
Overview & Compliance
Kyropan-D integrates potent proton pump inhibition from Pantoprazole with the prokinetic pro-motility action of sustained-release Domperidone. It eliminates burning acid reflux and controls nausea for sustained 24-hour relief.
Inquire About Kyropan-D
Fill in the form below and our medical affairs representative will follow up with complete technical and supply details.
Other Formulations in Our Range
Kyrocep-CV
10x10 TabletsCefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg tablets
Paradase
10x10 TabletsAceclofenac 100 mg, Paracetamol 325 mg, Serratiopeptidase 15 mg
Syrup Multisine
200 mlSyrup of B-complex and L-lysine